Zur Rose Group AG / Key word: AGMEGM
Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG
04.05.2023 / 20:45 CET/CEST
Frauenfeld, 4 May 2023
Press. | May 4, 2023
Alexander Thiel from Jefferies retains his positive opinion on the stock with a Buy rating. The target price continues to be set at CHF 60. | April 20, 2023
In a research note, Warburg Research analyst Michael Heider has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at CHF 80. | April 20, 2023
In a research note published by Alexander Thiel, Jefferies advises its customers to buy the stock. The target price is lowered from CHF 64 to CHF 60. | April 17, 2023